News Releases
- Galderma Announces Nemolizumab Data at American Academy of Dermatology (AAD) Annual Meeting
- Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for RET Receptor Tyrosine Kinase Inhibitor, Selpercatinib for RET Fusion-Positive Solid Tumors
- Eli Lilly and Company Discloses Form 10-K Including Orforglipron Related Information
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary